Search Results - Gregory J. Dore

O1 Hepatitis C: the treatment landscape in 2017 by Gregory J. Dore

Connect to this object online.

Hepatitis C virus incidence among injecting drug users on opioid replacement therapy by Richard Hallinan, Andrew Byrne, Janaki Amin, Gregory J. Dore

Connect to this object online.

Blood‐borne viruses and their survival in the environment: is public concern about community needlestick exposures justified? by Sandra C. Thompson, Clem R. Boughton, Gregory J. Dore

Connect to this object online.

Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney by Bethany White, Gregory J. Dore, Andrew Lloyd, William Rawlinson, Lisa Maher

Connect to this object online.

Late HIV presentation among AIDS cases in Australia, 1992-2001 by Ann M. McDonald, Yueming Li, Gregory J. Dore, Hugo Ree, John M. Kaldor

Connect to this object online.

Review of antenatal testing policies and practice for HIV and hepatitis C infection by Jenean D. Spencer, Diane Tibbits, Christine Tippet, Catherine Mead, John M. Kaldor, Gregory J. Dore

Connect to this object online.

Estimates of chronic hepatitis B virus infection in Australia, 2000 by Belinda G. O'Sullivan, Heather F. Gidding, Matthew Law, John M. Kaldor, Gwendolyn L. Gilbert, Gregory J. Dore

Connect to this object online.

Estimating the number of people who inject drugs in Australia by Sarah Larney, Matthew Hickman, Rebecca Guy, Jason Grebely, Gregory J. Dore, Richard T. Gray, Carolyn A. Day, Jo Kimber, Louisa Degenhardt

Connect to this object online.

Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, AustraliaResearch in context by Shane Tillakeratne, Sallie-Anne Pearson, Maryam Alavi, Behzad Hajarizadeh, Marianne Martinello, Matthew Law, Jacob George, Janaki Amin, Gail Matthews, Jason Grebely, Gregory J. Dore, Heather Valerio

Connect to this object online.

O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy by Marianne Martinello, Gregory J. Dore, Rohan I. Bopage, Robert Finlayson, David Baker, Mark Bloch, Ecaterina Filep, Jasmine Skurowski, Lanni Lin, Francois Lamoury, Sofia Bartlett, Tanya Applegate, Margaret Hellard, Gail V. Matthews

Connect to this object online.

Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep studyResearch in context by Rugiatu Bah, Yumi Sheehan, Xiaoying Li, Gregory J. Dore, Jason Grebely, Andrew R. Lloyd, Behzad Hajarizadeh, Andrew Lloyd, Behzad Hajarizadeh, Yumi Sheehan, Rugi Bah, Charlotte Li, Marianne Byrne, Tony Butler, Bridget Musarurwa, Elmira Hooshmand, Annabeth Simpson, Meya Alrayyani, Jason Grebely, Greg Dore, Nikki Price, Melissa Groom

Connect to this object online.

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines by Miquel Oliu-Barton, PhD, Bary S R Pradelski, PhD, Yann Algan, ProfPhD, Michael G Baker, ProfMD, Agnes Binagwaho, ProfPhD, Gregory J Dore, ProfPhD, Ayman El-Mohandes, MD, Arnaud Fontanet, ProfPhD, Andreas Peichl, ProfPhD, Viola Priesemann, PhD, Guntram B Wolff, PhD, Gavin Yamey, ProfMD, Jeffrey V Lazarus, PhD

Connect to this object online.